Stanley L Liauw

8PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer diagnosisInstruments and techniquesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 13, 2026
High-Risk Prostate Cancer Treated with Radiation Therapy: Favorable Outcomes in Men with PSA > 20 as the Sole High-Risk Factor.

Aoi Shimomura, Abed R Kawakibi, Muzamil Arshad

|Nov 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.

Deaglan McHugh, Matthew Dallos, Min Yuen Teo

|Jan 25, 2025
Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma Recurrence.

Rafi Kabarriti, Shane Lloyd, James Jabalee

|Jan 17, 2025
Online correction of intrafraction motion during volumetric modulated arc therapy for prostate radiotherapy using fiducial-based kV imaging: A cohort study quantifying the frequency of shifts and analysis of men at highest risk.

Lucas M Serra, Tianming Wu, Mark C Korpics

|Nov 11, 2022
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.

Phuoc T Tran, Kathryn Lowe, Hua-Ling Tsai

|Apr 21, 2021
A prospective clinical and transcriptomic feasibility study of oral-only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidity.

Benjamin E Onderdonk, Paige L Dorn, Carlos Martinez

Pageof 2

Frequent Collaborators

1 joint publications

Stanley I Gutiontov

1 joint publications

William Tyler Turchan

1 joint publications

Benjamin E Onderdonk

1 joint publications

Daniel W Golden